Home › Research › Topics › remote
remote
238 studies tagged remote, dated 1991-08-01 to 2026-10-29. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- A digital programme to prevent falls and improve wellbeing in people living with dementia in the community: Quantitative results from the KOKU-LITE feasibility study 2026-10-29
- Stable and Interpretable Cognitive Status Screening Using Longitudinal Wearable Data 2026-10-20
- Comorbidities of dementia in electronic health records: validation of a natural language processing app and comparison with data linkage 2026-10-19
Studies
238 studies carry this tag.
Date range
1991 to 2026
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 12
- Journal of Alzheimer's disease : JAD 12
- medRxiv 12
- Research Square 11
- Alzheimer's & dementia (Amsterdam, Netherlands) 9
107 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Sixty participants (30 intervention, 30 control) were recruited and followed up between March 2024 to September 2025.
-
Wearable devices repeatedly measure activity, sleep, and nocturnal physiology, but their value for three-class cognitive screening remains uncertain.
-
MedCAT Comorbidity demonstrated predictive ability for mortality (HR 1.11 per condition), although the model fit was better using comorbidity from hospital admission data.
-
Standardized cognitive and functional assessments, such as those in the National Alzheimer’s Coordinating Center (NACC) Uniform Data Set (UDS), are central to detecting and monitoring Alzheimer’s disease, yet their administration and scoring depend on trained examiners who record and score responses by hand.
-
Model-inferred and reference diagnoses showed exact agreement rates from 18.8% to 56.2% with poor to slight chance-corrected agreement (Cohen’s κ = −.178 to .196).
-
Although smartphone usage time is not directly associated with ikigai in older adults, it may reflect preserved physical and cognitive abilities required to navigate digital environments.
-
16/100
We introduce Dementia Language Models (DeLMs) – generalizable and controllable representations of cognitive impairment through language – alongside an evaluation framework for establishing their validity and clinical grounding.
-
Average adherence was 41%. Despite this, remote measures demonstrated excellent reliability (ICCs > 0.90 after 10 sessions) and strong construct validity, with tasks loading onto memory, attention, and executive function domains.
-
This study provides quantitative evidence supporting the complementary use of multiple cognitive assessment tools.
-
Implementation of an EHR-enabled AD care pathway was associated with improved adoption of guideline-concordant cognitive assessment and recommended diagnostic evaluation in primary care across three health systems.
-
Amyloid-β deposition begins in the earliest preclinical stages of Alzheimer's disease, long before cognitive decline is detectable by standard clinical assessments, which are often limited by ceiling effects and create a need for non-invasive, scalable markers.
-
Digital literacy is a meaningful predictor of HRQoL in older adults with intact or mildly impaired cognition, underscoring its potential as an intervention target in digital health strategies.
-
The mean DDAF score was 40.56 ± 21.18 among digital natives (18-29 years), 34.93 ± 21.88 among the digital transition generation (30-44 years), and 25.17 ± 18.59 among digital immigrants (45-70 years) (p < 0.001).
-
16/100
Individuals with MCI and AD exhibit marked deficits in the performance and accuracy of upper-limb reaching and catching movements when assessed in a VR environment.
-
16/100
We examined whether natural language processing and acoustic analysis of spoken biographical recall could identify lexical and temporal speech features associated with language and memory performance in TLE.
-
While the widespread adoption of electronic medical records (EMRs) has significantly improved healthcare efficiency and resource allocation, the sensitivity of medical data poses serious privacy breach risks.
-
This interdisciplinary, prototype-centered AI education program was associated with significant short-term improvements in students’ perceived AI knowledge, digital mental health readiness, interdisciplinary collaboration, innovation capacity, STEM career readiness, and solution-design ability.
-
Of 352 records identified, five studies involving 245 participants were included.
-
Detection and characterisation of dementia and Mild Cognitive Impairment (MCI) is essential for diagnosis and to support recruitment of patients into trials of disease-targeted therapies.
-
Practice testing with detailed, corrective feedback is an effective intervention for targeting caregivers’ dementia-related knowledge.
-
Of 300 randomized participants, 277 participants (mean age, 72.9 years; 69.3% female) were included in the modified intention-to-treat analysis (142 in the MLI group and 135 in the control group).
-
Engaging 55 research staff across 25 sites and 3 physician-reviewers, this study is the first to demonstrate feasibility of a VANE as an efficient neurological examination model enabled by commonly used devices.
-
Cognitive impairment is a prevalent symptom extending from physiological ageing to disease.
-
Default thresholds yielded 20–23% precision with 94– 100% recall—unacceptable for caregiver-facing alerts.
-
Changes in four outcome measures from initiation of treatment to discharge were evaluated for statistical significance: quality of life and three therapist-rated Functional Communication Measures (FCMs) of overall cognition, language expression, and language comprehension.
-
These findings support mApp-FTT validity as a measure of motor function across neurodegenerative conditions.
-
Neurodegenerative conditions increasingly adopt digital and assistive technologies in community and home-based settings to support independence, symptom management and quality of life.
-
The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) is the most validated and widely-used ALS-specific cognitive assessment tool, yet paper-and-pencil manual scoring introduces inter-rater variability that can significantly limit reliability and reproducibility in multi-site clinical trials.
-
16/100
Strengths and limitations of this study This study evaluates a digitally enabled remote monitoring model for people living with dementia that integrates passive in-home sensors and algorithm-derived digital biomarkers to detect clinically relevant changes such as infection risk, behavioural disturbance and physiological deterioration.
-
The slow progression of Alzheimer's disease (AD) poses a challenge for the quantification of early disease-driven cognitive decline.
-
Agreement for the global CDR was moderate (κ = 0.53, 95% CI: 0.47-0.59).
-
Adherence was high (82.2%) and usability favorable.
-
In response to correspondence from Cognivue, Inc. regarding our publication (Jannati et al., 2025), we clarify that our analysis employed a rigorous paired-sample design using the same 930 participants from the Bio-Hermes-001 study for both the Digital Clock and Recall® (DCR) and Cognivue Clarity® assessments.
-
A RAG-based LLM pipeline without structured ICD codes improved dementia ascertainment from EHR data compared with ICD-based rules and keyword-based filtering.
-
16/100
The mean age was 66.8 years and 21% had CI.
-
Identifying scalable, objective markers of dementia risk is essential for early prevention and intervention.
-
54/100
BackgroundCognitive impairment significantly impacts the quality of life in patients with neurodegenerative disorders, including Huntington's disease (HD), Parkinson's disease (PD), and Alzheimer's disease (AD).ObjectiveThis study aims to assess the utility of MemTrax, a contemporary digital continuous recognition task platform originally developed for AD, as an effective tool for revealing cognitive and clinical motor impairments in HD and PD populations as aligned with respective disease staging.
-
There were 719 respondents (276 people with dementia, 443 carers).
-
After the clinical implementation of amyloid-β-targeting therapies for people with cognitive impairment due to Alzheimer's disease (AD), there is an urgent need to efficiently identify this patient population in primary care.
-
Over six months, the intervention group showed a stable global cognitive function score (Mini Mental Status Examination), whereas the control group showed a cognitive decline (ANCOVA-interaction: F1, 14 = 5.083, p = .041; controlled for disease duration and education).
-
Correlations between in-person and T-COG scores were of moderate to large magnitude (Pearson r: 0.57 to 0.80, intraclass correlation coefficients: 0.52 to 0.79).
-
Our analysis yielded three major a marked acceleration in research activity since 2020, a convergence of clinical needs with technological advancements, and the inherently interdisciplinary nature of this field.
-
With the global population rapidly aging, dementia has emerged as a major public health concern.
-
Our results demonstrate that the multi-modal classifier achieved strong classification performance (accuracy = 68.64%; precision = 73.97%; F1-score=74.48%), with the highest recall (76.39%) from a model incorporating demographics and driving features, and prediction performance (accuracy = 70.48%; precision = 71.88%; F1-score = 74.80%, recall = 77.97%).
-
A total of 57 articles were included in the review, including 3182 participants.
-
Characterizing subtle cognitive changes in preclinical Alzheimer's disease (AD) is difficult using traditional neuropsychological assessments.
-
The data of 1734 participants (1158 with AD, 105 with DLB, 46 with VaD, and 425 with CN) were analyzed.
-
48/100
This case series elucidates pathological signs for diagnosis in two patients with Dementia.
-
We received completed questionnaires from physicians for 45 patients.
-
Monitoring and assessing the progression of symptoms in neurodegenerative diseases, including Alzheimer's and Parkinson's disease, are critical for improving patient outcomes.
From across this tag
8 of the 238 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 8. The same 8 appear here every time.
- Supervised Digital Neuropsychological Tests for Cognitive Decline in Older Adults: Usability and Clinical Validity Study
- Performance and validation of a digital memory test across the Alzheimer's disease continuum
- Scoping review: the empowerment of Alzheimer's Disease caregivers with mHealth applications
- Montreal Cognitive Assessment (MoCA) XpressO: Validation of a digital self-administered cognitive prescreening tool
- How to engage patients in computerized cognitive training: a cognitive rehabilitation expert's perspective
- Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study
- Computerized cognitive training with older adults: a systematic review
- Protecting cognition from aging and Alzheimer's disease: a computerized cognitive training combined with reminiscence therapy